skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Metallic Stents for Tracheobronchial Pathology Treatment

Journal Article · · Cardiovascular and Interventional Radiology
 [1];  [2];  [3];  [4];  [5]
  1. University of Zaragoza, Surgical Pathology Unit, Animal Pathology Department (Spain)
  2. University of Zaragoza, Minimally Invasive Techniques Research Group (GITMI) (Spain)
  3. Marly Clinic, Pulmonology Department (Colombia)
  4. Lozano Blesa Clinical University Hospital, Pulmonology Department (Spain)
  5. Health Science Center, Interventional Radiology Deparment (United States)

Purpose: To present the 7-year experience of the treatment of benign and malignant tracheobronchial stenoses using metallic stents. Patients and Methods: One hundred twenty-three stents were inserted in 86 patients (74 benign and 12 malignant stenoses). Ninety-seven stents were placed in the trachea and 26 in the bronchi. The procedures were performed under fluoroscopic and flexible bronchoscopic guidance with the patient under light sedation. In cases of severe stenotic lesions or obstructions, laser resection was performed before stent placement. Clinical and functional pulmonary data were recorded before and 3 months after the procedure. Follow-up involved clinical data and radiographic techniques at 48 h and at 1-, 3-, 6-, and 12-month intervals. Results: The technical success was 100 %. Dyspnea disappearance, forced expiratory volume in the first second, and pulmonary functional data improvement was observed in all patients (p < 0.001). Complications were detected in 23 patients (26.7 %). Mean follow-up time was 6.3 {+-} 1.2 months in patients with malignant lesions and 76.2 {+-} 2.3 months patients with in benign lesions. By the end of the study, 100 % of patients with malignant pathology and 6.7 % of patients with benign lesions had died. Conclusion: Endoluminal treatment of tracheobronchial stenosis with metallic stents is a therapeutic alternative in patients who are poor candidates for surgery. In unresectable malignant lesions, the benefit of metallic stenting is unquestionable. In benign lesions, the results are satisfactory, but sometimes other interventions are required to treat complications. New stent technology may improve these results.

OSTI ID:
22207970
Journal Information:
Cardiovascular and Interventional Radiology, Vol. 36, Issue 6; Other Information: Copyright (c) 2013 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
Country of Publication:
United States
Language:
English

Similar Records

Treatment of Inoperable Tracheobronchial Obstructive Lesions with the Palmaz Stent
Journal Article · Mon Mar 15 00:00:00 EST 1999 · Cardiovascular and Interventional Radiology · OSTI ID:22207970

Outcomes of Temporary Partially Covered Stent Placement for Benign Tracheobronchial Stenosis
Journal Article · Mon Aug 15 00:00:00 EDT 2016 · Cardiovascular and Interventional Radiology · OSTI ID:22207970

Removal of Retrievable Self-Expandable Metallic Tracheobronchial Stents: An 18-Year Experience in a Single Center
Journal Article · Tue Nov 15 00:00:00 EST 2016 · Cardiovascular and Interventional Radiology · OSTI ID:22207970